Trials / Unknown
UnknownNCT05125757
Lifestyle Modification in Psoriatic Patients With Fatty Liver
Response of Fatty Liver to Lifestyle Modification in Psoriasis Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Several recent reports have shown an increased prevalence of nonalcoholic fatty liver disease (NAFLD) in those with psoriasis, which may reflect the increased occurrence of metabolic syndrome in this patient population.
Detailed description
the recruitment of 60 fatty live men with chronic disease, psoriasis, will be classified to lifestyle modification group (foe 12 weeks, this patients will take supervised energy or diet restriction program plus their usual immunosuppressive drugs ) and control group will continue their drug program only)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | lifestyle modification | for 12 week, the patients of this group will receive their usual immuno-modulating therapy plus life style modification (energy or diet restriction in addition to daily walking, 15000 steps) |
| OTHER | usual lifestyle | the patients will receive the usual immuno-modulating therapy with continued usual diet and activities |
Timeline
- Start date
- 2021-09-13
- Primary completion
- 2022-03-15
- Completion
- 2022-03-15
- First posted
- 2021-11-18
- Last updated
- 2021-11-18
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05125757. Inclusion in this directory is not an endorsement.